Educating Patients on IOL Options Is Key

• by Allison Young, MD, Jana Waters, MD

• April 1, 2025

Lutein Supplementation May Improve Outcomes in Early AMD

Meta-analysis found statistically significant improvements, with clearest benefits in early-stage disease

• by Andrea Surnit

• May 5, 2026

• 3 min

IL-6 Inhibitor Vamikibart Shows Efficacy Signals in DME Trial

At ARVO 2026, Arshad M. Khanani, MD, MA, FASRS, presented phase 2 data on vamikibart, an IL-6 inhibitor, in diabetic macular edema.

• by Arshad M. Khanani, MD, MA, FASRS, Arshad M. Khanani, MD, MA, FASRS

• May 1, 2026

• 4 min

Inside Focus A-Eye’s Inaugural Meeting

Sharon Bakalash, MD, PhD, CBA, describes how the interdisciplinary pre-ARVO forum explored ways to move AI from concept to clinic.

• by Sharon Bakalash, MD, PhD, CBA

• May 1, 2026

• 2 min